Eko is a healthcare technology company that focuses on enhancing the detection and diagnosis of cardiovascular and lung diseases through advanced digital stethoscopes and AI-powered software. Founded by Connor Landgraf and his classmates at the University of California, Berkeley, Eko transforms traditional analog stethoscopes into smart devices that improve clinicians' ability to hear, visualize, and analyze heart and lung sounds.

Eko's core products include the Eko CORE Digital Stethoscope, which is FDA-cleared and features active noise cancellation, and the DUO ECG + Digital Stethoscope, the first device to combine digital stethoscope functionality with single-lead ECG recording. Their AI-powered software integrates with these stethoscopes to automatically detect heart conditions and supports clinicians with visual heart sound and ECG tracings, as well as patient exam record storage for ongoing monitoring.

Eko's solutions are designed for healthcare professionals, enhancing clinical expertise and improving patient outcomes. The company operates on a business model that includes product sales and subscription-based access to their AI diagnostic software, along with services for telemedicine and medical report sharing.